Plasminogen Activator Inhibitor-1 and Pericardial Fat in Individuals with Type 2 Diabetes Mellitus

Metabolic Syndrome and Related Disorders
Omar BayomyGail K Adler

Abstract

Plasminogen activator inhibitor-1 (PAI-1) is implicated in the pathophysiology of cardiovascular disease (CVD) and increased in individuals with type 2 diabetes mellitus (T2DM). Adipose tissue produces PAI-1, and pericardial fat is a CVD risk factor. We sought to determine the relationship between PAI-1 and pericardial fat in males and females with well-controlled T2DM. The study population consisted of 32 males and 19 females, aged 35-70 years with T2DM, without clinical evidence of CVD or other active medical problems except for hypertension. Subjects were studied under good cardiometabolic control. Study procedures included fasting blood work and cardiovascular imaging. Cardiac magnetic resonance imaging of the heart was used to identify and quantify pericardial fat from the bifurcation of the pulmonary trunk to the last slice containing cardiac tissue. PAI-1 was positively correlated with pericardial fat (β = 0.72, r = 0.72, P < 0.001) as well as with homeostatic model assessment of insulin resistance (r = 0.31, P = 0.03) and serum triglycerides (r = 0.27, P = 0.05). In a multivariable regression model, controlling for insulin sensitivity, triglycerides, and body mass index, pericardial fat was independently associated with...Continue Reading

References

Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J SchneidermanD J Loskutoff
Sep 1, 1989·Metabolism: Clinical and Experimental·P VagueC Atlan
Jun 15, 2000·The New England Journal of Medicine·H P Kohler, P J Grant
Apr 23, 2003·Journal of the American College of Cardiology·Marcelo F Di CarliJoel Ager
Jan 7, 2005·Journal of Thrombosis and Haemostasis : JTH·H R Lijnen
Aug 17, 2005·Journal of Thrombosis and Haemostasis : JTH·D E Vaughan
Dec 18, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Alexis E MalavazosBruno Ambrosi
Jun 7, 2008·Obesity·Jingzhong DingUNKNOWN Multi-Ethnic Study of Atherosclerosis
Aug 7, 2009·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·M Mohsen Ibrahim
Dec 1, 2009·Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography·Gianluca Iacobellis, Howard J Willens
Oct 1, 2011·Journal of the American College of Cardiology·Manu Kaushik, Yeruva M Reddy
Sep 22, 2012·Diabetes Care·David J Schneider, Burton E Sobel
Aug 2, 2013·Diabetes Care·Edoardo MannucciPaolo Pozzilli
Apr 9, 2015·Nature Reviews. Endocrinology·Gianluca Iacobellis
Aug 8, 2015·Circulation·Caroline S FoxUNKNOWN American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Ca

❮ Previous
Next ❯

Methods Mentioned

BETA
ELISA
biopsies

Clinical Trials Mentioned

NCT00865124

Software Mentioned

SPSS
QMass MR

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.